Clinical trial
Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome
NCT07320612 is registered in ClinicalTrials.gov with University of Child Health Sciences and Children's Hospital, Lahore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome
- Lead sponsor
- University of Child Health Sciences and Children's Hospital, Lahore
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 8, 2025
- Completion date
- October 8, 2025
- Enrollment
- 160 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.